Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr;2(1):28-36.
doi: 10.1159/000444736. Epub 2016 Mar 8.

The Nucleotide Oligomerization Domain-Like Receptors in Kidney Injury

Affiliations
Review

The Nucleotide Oligomerization Domain-Like Receptors in Kidney Injury

Xiaojie Wang et al. Kidney Dis (Basel). 2016 Apr.

Abstract

Background: Inflammation is a hallmark of almost all forms of renal injury and the activation of the innate immune system is of importance in the development of many kidney diseases. Pattern recognition receptors (PRRs) act as sensors of the innate immune system to detect pathogen- or damage-associated molecular patterns, which initiate immune responses to resolve infections and repair damaged tissues. Abnormalities in PRR activation will lead to excessive inflammation.

Summary: Nucleotide oligomerization domain (NOD)-like receptors (NLRs) are recently identified intracellular PRRs that are essential to innate immune responses and tissue homeostasis. A better understanding of the function of NLRs will provide unexpected opportunities to develop new therapies for kidney diseases by modulation of the innate immune system.

Key messages: NLRs are constitutively expressed in the kidney and emerging evidence has shown that activation of NLRs plays an important role in the pathogenesis of renal injury. Among NLRs, NOD2 and NLRP3 inflammasome are the best characterized members in the kidney. In this review, we summarize current knowledge about the pathological mechanisms that are related to NOD2 and NLRP3 inflammasome in various kidney diseases by their canonical and non-canonical effects and discuss the opportunities of pharmacological targeting of NLR-mediated signaling pathways at multiple levels for the treatment of renal disease.

Keywords: Inflammation; Kidney disease; NLRP3; NOD2; Pattern recognition receptors.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Classification and molecular structures of NLRs. AD = Activator domain; BIR = baculovirus inhibitor of an apoptosis protein repeat; FIIND = function to find domain; LRR = leucine-rich repeat; NACHT = NAIP (neuronal apoptosis inhibitor protein), C2TA (MHC class 2 transcription activator), HET-E (incompatibility locus protein from Podospora anserina) and TP1 (telomerase-associated protein); NAD = NACHT-associated domain.
Fig. 2
Fig. 2
Summarized recent findings on the role of NOD2 and its canonical and non-canonical effects in kidney injury.
Fig. 3
Fig. 3
Summarized recent findings on the function, activation and canonical and non-canonical effects of NLRP3 in kidney injury. EMT = Epithelial-mesenchymal transition.

Similar articles

Cited by

References

    1. Vande Walle L, Van Opdenbosch N, Jacques P, et al. Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis. Nature. 2014;512:69–73. - PMC - PubMed
    1. Heneka MT, Kummer MP, Stutz A, et al. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature. 2013;493:674–678. - PMC - PubMed
    1. Kayagaki N, Warming S, Lamkanfi M, et al. Non-canonical inflammasome activation targets caspase-11. Nature. 2011;479:117–121. - PubMed
    1. Wada J, Makino H. Innate immunity in diabetes and diabetic nephropathy. Nat Rev Nephrol. 2016;12:13–26. - PubMed
    1. Bradbury J. Zebularine: a candidate for epigenetic cancer therapy. Drug Discov Today. 2004;9:906–907. - PubMed

LinkOut - more resources